Skip to main content

Advertisement

Table 1 Infection burden of VVC in groups receiving different treatments pior-infection

From: Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis

Treatment Infection burden of VVC (log10 CFU) post-inoculation
PBS 4.585 ± 0.112
L.casei/pPG612.1-BLF 4.404 ± 0.040*
L.casei/pPG612.1 4.643 ± 0.035
L.casei 4.633 ± 0.032
  1. *P < 0.01 in comparison with PBS, L.casei/pPG612.1-BLF and L.casei groups